Genovis

Genovis EBIT

The EBIT of Genovis (GENO.ST) as of Oct 17, 2026 is 27.49 M SEK. In the previous year, EBIT was 45.73 M SEK — a change of -39.89% (lower).

EBIT

27.49 MSEK

YoY

-39.89%

Last updated:

In 2025, Genovis's EBIT was 27.49 M SEK, a -39.89% increase from the 45.73 M SEK EBIT recorded in the previous year.

The Genovis EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
54.22 M SEK
Jan 1, 2024
45.73 M SEK
Jan 1, 2025
27.49 M SEK
Jan 1, 2026 (e)
20.44 M SEK
Jan 1, 2027 (e)
39.96 M SEK
Jan 1, 2028 (e)
56.39 M SEK
Jan 1, 2029 (e)
75.04 M SEK
Jan 1, 2030 (e)
92.96 M SEK
The Genovis EBIT history
YEAREBITYoY
est92.96 MSEK+23.89%
est75.04 MSEK+33.06%
est56.39 MSEK+41.14%
est39.96 MSEK+95.44%
est20.44 MSEK-25.63%
27.49 MSEK-39.89%
45.73 MSEK-15.66%
54.22 MSEK+533.63%
8.56 MSEK-65.13%
24.54 MSEK+256.39%
6.89 MSEK-49.08%
13.52 MSEK-1,507.85%
-960,640.00SEK-87.74%
-7.84 MSEK-46.95%
-14.77 MSEK-25.50%
-19.82 MSEK-3.16%
-20.47 MSEK+28.06%
-15.99 MSEK-20.79%
-20.18 MSEK+46.82%
-13.75 MSEK+22.36%
-11.23 MSEK-10.52%
-12.55 MSEK-50.61%
-25.42 MSEK+110.78%
-12.06 MSEK+36.58%
-8.83 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genovis Revenue

Genovis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
158.23 M SEK
54.22 M SEK
61.50 M SEK
Jan 1, 2024
130.36 M SEK
45.73 M SEK
32.92 M SEK
Jan 1, 2025
128.95 M SEK
27.49 M SEK
23.50 M SEK
Jan 1, 2026 (e)
143.85 M SEK
20.44 M SEK
20.13 M SEK
Jan 1, 2027 (e)
180.91 M SEK
39.96 M SEK
35.02 M SEK
Jan 1, 2028 (e)
220.98 M SEK
56.39 M SEK
48.44 M SEK
Jan 1, 2029 (e)
265.00 M SEK
75.04 M SEK
65.47 M SEK
Jan 1, 2030 (e)
308.00 M SEK
92.96 M SEK
81.83 M SEK

Genovis Margins

Genovis stock margins

The Genovis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genovis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genovis.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
90.42 %
34.27 %
38.87 %
Jan 1, 2024
88.20 %
35.08 %
25.25 %
Jan 1, 2025
21.32 %
21.32 %
18.22 %
Jan 1, 2026 (e)
21.32 %
14.21 %
13.99 %
Jan 1, 2027 (e)
21.32 %
22.09 %
19.36 %
Jan 1, 2028 (e)
21.32 %
25.52 %
21.92 %
Jan 1, 2029 (e)
21.32 %
28.32 %
24.70 %
Jan 1, 2030 (e)
21.32 %
30.18 %
26.57 %

Genovis Stock analysis

What does Genovis do? Genovis AB is a Swedish company that offers biotechnology solutions for drug research and diagnostic industries. The company was founded in Lund, Sweden in 1999 and currently employs over 30 employees. Genovis began with the development of enzymes for protein-based therapeutics, but over time expanded its business to include enzymes for improved analysis methods in mass spectrometry. Genovis has become a leading provider of innovative enzyme solutions and proteomics tools for biomedical research. The company's business model is based on providing specially developed enzymes and proteomics tools to companies in drug research and diagnostic industries. Genovis has two main business areas: marketing enzymes and providing peptide synthesis services. The first business area is the marketing of enzymes for the separation of glycosylated proteins in mass spectrometry. The company develops and produces these enzymes for various applications such as Alzheimer's research, cancer research, and infectious diseases. Genovis is also an important provider of enzymes for the investigation of antibody-drug conjugates used in novel therapeutic approaches. The second business area is providing peptide synthesis services. The company also has a diversified biotechnology infrastructure and offers analysis and synthesis services for peptides in various fields, such as immunotherapy and diagnostics. Genovis' product portfolio includes a variety of enzymes that have broad application in drug research and diagnostic industries. This includes enzymes for antibody proteolysis, enzymes for the synthesis of glycoconjugates, and enzymes for conjugated protein analysis. In addition, the company also offers specialized kits for protein analysis. Genovis kits always include all necessary components such as proteases, buffer systems, and instructions to conduct the offered experiments. In conclusion, Genovis is a leading company in the biotechnology industry that offers innovative enzyme solutions and proteomics tools for a variety of applications in medical research and diagnostics. With its diversified biotechnology infrastructure and dedicated employees, the company can meet the growing needs of its customers in the science and industry sectors and has become a key partner in the healthcare industry. Genovis is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Genovis's EBIT

Genovis's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Genovis's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Genovis's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Genovis’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Genovis stock

EBIT of Genovis is 27.49 M SEK in 2025.

EBIT of Genovis changed from 45.73 M SEK to 27.49 M SEK, representing a -39.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Genovis since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Genovis historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Genovis

All Key Metrics — Genovis